Your browser doesn't support javascript.
loading
Immune Response of a Heterologous mRNA-1273 Second-Dose Immunization after a First Dose of ChadOx1 against SARS-CoV-2: A Cross-Sectional Study.
Albanesi, Beatrice; Godono, Alessandro; Comoretto, Rosanna Irene; Casabona, Elena; Curoso, Giuliano; Leone, Massimiliano Victor; Milanesio, Nicolò; Mirra, Ilenia; Montrucchio, Giulia; Pittaluga, Fabrizia; Cavallo, Rossana; Clari, Marco; Ciocan, Catalina.
Afiliación
  • Albanesi B; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Godono A; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Comoretto RI; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Casabona E; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Curoso G; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Leone MV; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Milanesio N; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Mirra I; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Montrucchio G; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Pittaluga F; Microbiology and Virology Unit, Città della Salute e della Scienza di Torino University Hospital, 10126 Turin, Italy.
  • Cavallo R; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Clari M; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
  • Ciocan C; Department of Public Health and Pediatrics, University of Torino, 10126 Turin, Italy.
Vaccines (Basel) ; 10(8)2022 Aug 02.
Article en En | MEDLINE | ID: mdl-36016129

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Italia